Now prescribing BPC-157, TB-500, Semax, MOTS-c and Epitalon

PepScribe

Cost guide · GLP-1 therapy

Weight loss injection cost: branded vs. compounded. | Reddit

Last updated November 3, 2026

More: Clinical standards · Pharmacy partners · Is PepScribe legit?

Weight loss injection cost is one of the most common questions patients research before starting GLP-1 therapy. Without insurance, the makers now sell branded Wegovy for $349 a month and Zepbound for $299 to $699 a month by dose, while compounded semaglutide and tirzepatide, prescribed and dispensed through licensed clinical channels, typically cost $150 to $350 per month. Here is how to read that gap accurately.

Quick answer

Weight loss injections cost roughly $150 to $350 per month for clinician-prescribed compounded semaglutide or tirzepatide from a licensed U.S. 503A pharmacy, versus $199 to $699 per month for branded Wegovy or Zepbound bought direct from the makers without insurance.

The gap reflects the absence of brand R&D amortization, not a different active molecule; compounded products are not FDA-approved and are dispensed only on a prescription a clinician writes for you.

Key takeaways

  • Bought direct from Novo Nordisk or Eli Lilly without insurance, branded Ozempic, Wegovy, Mounjaro, and Zepbound run $199–$699/month by product and dose.
  • Clinician-prescribed compounded semaglutide or tirzepatide from a licensed 503A pharmacy typically runs $150–$350/month.
  • Compounded preparations are not FDA-approved finished drugs and are not the same as the branded products; each one is prepared by a licensed US 503A pharmacy against a single patient’s prescription.
  • The honest total cost includes the consult fee, any labs, supplies, and follow-ups — not just the medication sticker price.

Why is there such a wide cost range for weight loss injections?

GLP-1 receptor agonists have become the dominant pharmacological approach to weight management in recent years. Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) are both weekly subcutaneous injections that reduce appetite, slow gastric emptying, and produce meaningful weight reduction in clinical trials.

For most patients researching these medications, cost is the first friction point. Two fundamentally different access pathways exist:

Branded (manufacturer) pathway

Branded GLP-1 medications are FDA-approved finished drug products manufactured by Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide). Without insurance, both makers now sell them direct at self-pay prices:

  • Wegovy (semaglutide 2.4mg): $349 a month at every pen dose through NovoCare Pharmacy, or $199 for each of the first two months at the 0.25 mg and 0.5 mg starting doses through December 31, 2026. This is the FDA-approved formulation indicated for chronic weight management.
  • Ozempic (semaglutide 0.5–2mg): $349 a month for the 0.25 mg, 0.5 mg, and 1 mg pens and $499 for 2 mg through NovoCare Pharmacy, with the same $199 offer for the first two months. Indicated for Type 2 diabetes; widely used off-label for weight management.
  • Zepbound (tirzepatide 2.5–15mg): $299 a month at 2.5 mg and $399 at 5 mg through LillyDirect; 7.5 mg to 15 mg cost $449 when you refill within 45 days, otherwise $499 to $699. FDA-approved for chronic weight management.
  • Mounjaro (tirzepatide 2.5–15mg): From $499 a month at every dose through LillyDirect. Indicated for Type 2 diabetes.

Insurance coverage can dramatically reduce these costs for eligible patients. Coverage criteria vary by plan, insurer, and indication. Manufacturer savings cards may apply for commercially insured patients who qualify.

Compounded pathway

The compounded pathway starts with a prescriber. A licensed clinician evaluates the patient and writes for that one person, and a licensed 503A pharmacy in the USA prepares the prescription under state pharmacy board oversight and USP sterile standards. PepScribe’s GLP-1 preparations are combinations, semaglutide with cyanocobalamin and tirzepatide with cyanocobalamin, dosed for the individual patient.

Compounded semaglutide and tirzepatide are preparations of the respective drug substances compounded by licensed 503A pharmacies and FDA-registered facilities under individual clinician prescriptions. They are not FDA-approved finished drug products, are not manufactured by the original brand holders, and have not gone through the branded-drug approval process. Quality depends on the pharmacy — 503A pharmacies compound under state pharmacy board oversight and USP standards, which is different from FDA manufacturing oversight of finished drug products.

Cost through reputable compounding-based telehealth programs: approximately $150 to $350 per month depending on dose and provider, making them a meaningful alternative for patients without insurance coverage.

Important caveat: A compounded price is comparable to a branded price only once you know what is in the vial and who prepared it. Ask which pharmacy fills the prescription, what the preparation contains, and what the quoted price covers in month one versus month six.

The price gap between branded and compounded GLP-1s reflects R&D amortization and patent protection — not a difference in the active molecule.

How does the cost of branded vs. compounded GLP-1 injections compare?

ProductTypeMonthly cost (no insurance)FDA-approved?
Wegovy (semaglutide 2.4 mg)Branded$349 ($199 for the first 2 months)Yes
Ozempic (semaglutide 0.5–2 mg)Branded$349–$499Yes (diabetes)
Zepbound (tirzepatide 2.5–15 mg)Branded$299–$699Yes
Mounjaro (tirzepatide 2.5–15 mg)BrandedFrom $499Yes (diabetes)
Compounded semaglutide (503A pharmacy)Compounded$150–$350No — 503A compounded
Compounded tirzepatide (503A pharmacy)Compounded$150–$350No — 503A compounded

Branded prices are the makers’ self-pay prices from NovoCare Pharmacy and LillyDirect, checked October 2026. Compounded ranges are from telehealth provider disclosures as of 2025–2026. Insurance coverage and manufacturer savings programs can reduce branded costs further for eligible patients.

What a complete program actually costs

Sticker price for the medication is not the full picture. A responsible cost comparison should include:

  • Consultation fee: Initial clinical evaluation — this is often the largest variable across providers. Some charge $0 upfront and embed consultation cost in the medication price; others charge a separate consultation fee (often $49 to $199) that may or may not be credited toward treatment.
  • Lab work: Some programs require baseline labs (metabolic panel, HbA1c, thyroid) before prescribing. Cost varies by whether your primary care provider runs these or you pay out of pocket.
  • Medication: Monthly per-dose cost. Dose escalation schedules affect cost — starting doses are lower than maintenance doses, so month-one costs may differ from month-six costs.
  • Supplies: Syringes, needles, and alcohol swabs if not included. A minor cost item but worth confirming is included.
  • Follow-up visits: Ongoing clinical check-ins. Some providers include these; others charge per visit.

What should I look for in a compounded GLP-1 provider?

Not all compounding telehealth programs are equivalent. Quality markers to evaluate:

  • Licensed 503A pharmacy sourcing: Medication should be filled by a licensed 503A pharmacy in the United States. Not overseas. Not a gray-market supplier. Ask explicitly where your medication is compounded and by whom.
  • Actual clinician review: A licensed prescribing clinician should review your health history, contraindications, and current medications before prescribing — not a rubber-stamp algorithm.
  • Transparent pricing: Full program cost disclosed upfront, including consultation, medication, and any follow-up charges. Hidden fees are a quality signal.
  • Dose titration protocol: GLP-1 medications are titrated gradually to reduce GI side effects. A program that does not build a titration protocol into the prescription is cutting a clinical corner.
  • Monitoring: Ongoing check-ins allow the clinician to adjust dose, assess tolerability, and flag any concerns that require follow-up.

At PepScribe, compounded semaglutide and tirzepatide are prescribed following a clinician intake and compounded in the USA by licensed 503A pharmacies and FDA-registered facilities. No hidden overseas supply chain. The initial consultation fee is refundable if the clinician determines the medication is not appropriate for you.

GLP-1 therapy: what the clinical evidence shows

The clinical case for GLP-1 receptor agonists in weight management is among the strongest in modern obesity medicine. The STEP 1 trial of semaglutide 2.4mg found a mean weight reduction of approximately 15% over 68 weeks in adults without diabetes. The SURMOUNT-1 trial of tirzepatide found mean reductions of up to 22.5% at the highest dose over 72 weeks.

These are meaningful effects by any clinical benchmark. They come with side effects — primarily GI (nausea, vomiting, constipation, diarrhea), most pronounced during dose escalation and typically diminishing at maintenance dose.

Weight returns if medication is stopped without lifestyle changes embedded alongside it. GLP-1 therapy is not a permanent cure for obesity; it is a pharmacological support that lowers the appetite setpoint, making caloric reduction more sustainable. No outcome guarantees are appropriate because individual responses vary meaningfully.

Frequently asked questions

How much do weight loss injections cost per month?

Cost varies by product and by where you buy it. Without insurance, Novo Nordisk sells Wegovy and Ozempic pens direct for $349 a month ($199 for each of the first two months at the starting doses through 2026; Ozempic 2 mg is $499). Eli Lilly sells Zepbound for $299 to $699 a month by dose and Mounjaro from $499. Compounded semaglutide and tirzepatide, prescribed by licensed clinicians and compounded by 503A pharmacies and FDA-registered facilities, typically cost $150 to $350 per month.

Is compounded semaglutide the same as Ozempic?

No. Compounded semaglutide is a preparation of the semaglutide drug substance filled by a licensed 503A pharmacy under a clinician prescription. It is not an FDA-approved finished drug product, is not manufactured by Novo Nordisk, and has not gone through the same regulatory approval process as Ozempic or Wegovy. Do not equate a compounded preparation with a branded drug.

Does insurance cover weight loss injections?

Coverage is highly variable. Ozempic carries a Type 2 diabetes indication and is more commonly covered for that use. Wegovy has an obesity indication and is covered by some commercial plans and Medicare Part D under specific criteria. Tirzepatide products (Mounjaro for diabetes, Zepbound for weight) follow similar patterns. Many patients pay out of pocket — which is where compounded alternatives become economically significant.

What is included in the cost of a compounded GLP-1 program?

A complete program from a clinician-supervised telehealth provider typically includes a clinical consultation and medical intake, the prescribed medication compounded by a licensed pharmacy, injection supplies (syringes, alcohol swabs), and follow-up clinical check-ins. PepScribe includes the clinician consultation fee as a separate refundable charge, with the monthly medication cost distinct from the consult.

Are there hidden costs with compounded semaglutide or tirzepatide?

Reputable providers disclose all costs upfront. Watch for programs that advertise a low monthly medication price but charge separately for consultations, labs, or supplies without disclosing those costs. Ask explicitly: what is the total cost including the initial consultation, any required labs, medication, and supplies in month one and subsequent months?

Why is branded GLP-1 so expensive without insurance?

Branded GLP-1 medications carry high list prices reflecting the manufacturer's R&D investment, patent protection, and market positioning. Both makers now also sell direct to cash-pay patients for less than list: $349 a month for Wegovy through NovoCare Pharmacy and $299 to $699 for Zepbound through LillyDirect. Compounded semaglutide and tirzepatide, prescribed by a licensed clinician and prepared by a 503A pharmacy in the USA, sit well below the list price because no brand development or marketing cost is loaded into the price.

References

  1. Semaglutide 2.4 mg for Weight Management in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine — PubMed PMID 33567185 (2021).
  2. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial). New England Journal of Medicine — PubMed PMID 35658024 (2022).
  3. Compounding and the FDA: Questions and Answers. U.S. Food & Drug Administration (n.d.).
  4. Wegovy price guide: self-pay prices by dose. Novo Nordisk, NovoCare Pharmacy (checked 2026-10-06) (2026).
  5. Ozempic pill and pen price guide: self-pay prices by dose. Novo Nordisk, NovoCare Pharmacy (checked 2026-10-06) (2026).
  6. Zepbound self-pay prices by dose (KwikPen and single-dose vial). Eli Lilly and Company, LillyDirect (checked 2026-10-06) (2026).
  7. Mounjaro self-pay prices by dose. Eli Lilly and Company, LillyDirect (checked 2026-10-06) (2026).

What Reddit says

r/WeightLossAdvice31 commentsMar 2025

What's the real cost of weight loss injections? I see lots of cheap "first month" stuff but they never say how much until you sign up.

Nobody in the thread answers the question directly, and the closest thing to an answer is procedural: coverage often turns on a documented BMI threshold plus roughly six months of physician-supervised weight-loss attempts before a plan will pay. What the thread never surfaces is that the dose usually rises during titration, so any single monthly figure describes one point on a schedule rather than the whole course, and the other replies simply send the asker to drug-specific subreddits.

Posted on Reddit

See semaglutide and tirzepatide plans.

Clinician intake, compounded by licensed US 503A pharmacies and FDA-registered facilities. Transparent pricing — no hidden overseas supply chain, no surprise fees.

Written by B.A. Utterback.

Educational information only. Not medical advice. Treatment decisions are made by a licensed physician.